It also reduced hERG1B currents (IC50=66.8±9.8 μm), that is, the main hERG1 isoform expressed in leukemia cells.13, 14 Therefore, Cla blocks hERG1B with high efficacy, differently from classical hERG1 blockers like E4031. Here, KCNH2 is linked to leukemia.